Coageight 500 IU Injection Price In Pakistan

Coageight 500 IU Injection Price In Pakistan

Coageight 500 IU Injection is a recombinant blood-clotting factor medicine manufactured by AryoGen Pharmed. It contains recombinant Coagulation Factor VIII and is used to treat and help prevent bleeding episodes in people with Hemophilia A, a condition caused by a deficiency of Factor VIII.

It works by replacing the missing clotting factor, helping the blood form clots and control bleeding. It may also be prescribed to manage bleeding around surgical procedures in eligible patients.

2. Key Benefits

• Factor VIII replacement: Helps compensate for low or missing Factor VIII.

• Bleeding management: Helps control bleeding episodes associated with Hemophilia A.

• Bleeding prevention: May be prescribed as preventive treatment to reduce bleeding frequency.

• Surgical support: Can help manage bleeding risk during certain surgical procedures.

• Clotting support: Supports the body's normal blood-clotting process.

Benefits depend on the patient's condition, response to treatment, and prescribed dose.

3. Ingredients

• Active Ingredient: Recombinant Coagulation Factor VIII — 500 IU per vial.

• Other Ingredients: Excipients and reconstitution components depend on the manufacturer's formulation and packaging. Check the product leaflet or carton for the exact ingredient list.

Note: Confirm the specific formulation with the manufacturer or pharmacist before publishing a complete inactive-ingredient list.

4. Specifications

• Product Name: Coageight 500 IU Injection

• Active Ingredient: Recombinant Coagulation Factor VIII

• Strength: 500 International Units (IU)

• Dosage Form: Lyophilized powder for solution

• Route of Administration: Intravenous (IV)

• Manufacturer: AryoGen Pharmed

• Drug Category: Recombinant clotting-factor medicine

• Primary Indication: Hemophilia A

• Availability: Check with a licensed pharmacy in Pakistan.

• Prescription Required: Yes

5. How to Use

1. Use Coageight only under the direction of a hematologist or qualified healthcare professional.

2. The powder must be prepared using the specified diluent and manufacturer's instructions.

3. It is administered intravenously by a trained healthcare professional or by a patient or caregiver specifically trained in its use.

4. The dose depends on body weight, the severity and location of bleeding, Factor VIII levels, and the treatment plan.

5. Do not change the dose or treatment schedule without consulting your specialist.

6. Report any unexpected reaction or reduced treatment effectiveness to your healthcare professional.